MINNEAPOLIS, August 8, 2017 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today the launch of the GLUCOCARD Shine XL blood glucose monitoring system (BGMS). Highly accurate with a large LED screen, the GLUCOCARD Shine XL BGMS offers an ergonomic designed meter to provide a secure grip during testing. The large screen is intended to facilitate quick and easy viewing of blood glucose test results.
The GLUCOCARD Shine XL BGMS was introduced at the American Association of Diabetes Educators (AADE) meeting last week in Indianapolis, IN. The AADE is the largest gathering of diabetes educators in the US and ARKRAY is a sponsor of the meeting.
“The release of the GLUCOCARD Shine XL expands ARKRAY’s family of Shine BGMS,” said ARKRAY President Jonathan Chapman. “With the introduction of the GLUCOCARD Shine XL, ARKRAY now has one of the broadest lines of BGMS’ in the industry. This provides more choices for people living with diabetes and the healthcare professionals who care for them.”
The GLUCOCARD Shine XL uses the same test strips as the previously launched GLUCOCARD Shine BGMS, which has been proven in numerous studies to provide highly accurate test results while being easy to use.1
Diabetes, or diabetes mellitus, is a metabolic type of disease in which affected people have high blood glucose (blood sugar), either because insulin production is inadequate (Type 2), or because the islet cells in the pancreas no longer produce insulin (Type 1, sometimes referred to as juvenile diabetes). The ADA estimates that more than 30 million Americans suffer from either Type 1 or Type 2 diabetes and that 25.9% of Americans 65 years of age or greater may have diabetes.
About ARKRAY USA, Inc.
ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition. ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit www.arkrayusa.com.
- ARKRAY Clinical Compendium on Blood Glucose Monitoring Systems, 2014-2016